Calciphylaxis in the Upper GI Tract in an ESRD Patient: An Atypical Presentation and Review of Literature

Pallavi D Shirsat1, Kunal Sonavane2, Leonardo Ramirez Botana3

  • 1Department of Internal Medicine and Nephrology, Minden Medical Center, 1 Medical Plaza, Minden, 71055, Louisiana, USA.

Case Reports in Nephrology
|December 31, 2025
PubMed

Insights

Calcific uremic arteriolopathy (CUA) can manifest unusually in the stomach, causing severe bleeding in dialysis patients. Early suspicion of visceral CUA is crucial for high-risk end-stage renal disease patients.

Area of Science:

  • Nephrology
  • Pathology
  • Gastroenterology

Background:

  • Calcific uremic arteriolopathy (CUA), or calciphylaxis, is a rare vascular disease.
  • CUA predominantly affects end-stage renal disease (ESRD) patients on dialysis, causing painful skin ulcers.
  • Visceral CUA presentations are less common but can be life-threatening.

Purpose of the Study:

  • To report an exceptional case of gastric mucosal CUA.
  • To highlight upper gastrointestinal bleeding as an atypical presentation of CUA.
  • To emphasize the need for vigilance in diagnosing visceral CUA in ESRD patients.

Main Methods:

  • Case report of a dialysis-dependent ESRD patient.
  • Histopathologic examination of gastric biopsies.
  • Review of clinical presentation and outcome.

Main Results:

  • Gastric mucosal CUA was diagnosed in an ESRD patient presenting with severe upper gastrointestinal bleeding.
  • The patient had no preceding skin lesions.
  • Despite treatment, the patient experienced a fatal outcome due to poor adherence.

Conclusions:

  • Gastric CUA is a rare but critical diagnosis in ESRD patients.
  • Atypical visceral presentations of CUA require a high index of suspicion.
  • Prompt recognition and management are vital, though challenging.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
319
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
536
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
346
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
460
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
338